HCA-6
HCA-6 is a calcium-channel and P-glycoprotein blocker. HCA-6 can induce cancer cells apoptosis and increase anticancer activity of Cisplatin. HCA-6 also exhibits antibacterial activity against Bacillus subtilis. HCA-6 can be used for the research of cancer and infection, such as breast cancer[1].
Product Specifications
UNSPSC
12352005
Target
Apoptosis; Bacterial; Calcium Channel; P-glycoprotein
Related Pathways
Anti-infection; Apoptosis; Membrane Transporter/Ion Channel; Neuronal Signaling
Field of Research
Cancer; Infection
Smiles
O[C@@H]1[C@H](O)[C@@H](COC(COC2=CC=C(C3C(C(OCC)=O)=C(C)NC(C)=C3C(OCC)=O)C=C2[N+]([O-])=O)=O)O[C@H]1N(C(N4)=O)C=C(F)C4=O
Molecular Formula
C30H33FN4O14
Molecular Weight
692.60
References & Citations
[1]Chen G, et al. Novel dihydropyridines as potential calcium-channel and P-glycoprotein blockers applicable for chemotherapy sensitization. Bioorg Chem. 2025 Oct;165:109072.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC040391-100 1x 100 µL
CD81 / TAPA-1 (1.3.3.22), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC040034-100 1x 100 µL
Cytokeratin 8/18 (C-51), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC470745-100 1x 100 µL
CD45 / LCA (2B11 + PD7/26), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC400257-100 1x 100 µL
Cytokeratin, HMW (AE-3), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details